UBS Maintains Neutral on Xylem, Lowers Price Target to $112
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $138 to $112.
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $138 to $112.